4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-010688
Co-CEO gave up 320,835 shares (to pay taxes)
- Co-CEO acquired 672,302 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Chintu Co-CEO | 2025-03-03 | Option exercise | +579,710 | 1,092,276 | D | ||
| Patel Chintu Co-CEO | 2025-03-03 | Shares withheld for taxes | −274,307 | $8.76 | $2,402,929 | 817,969 | D |
| Patel Chintu Co-CEO | 2025-03-04 | Option exercise | +92,592 | 910,561 | D | ||
| Patel Chintu Co-CEO | 2025-03-04 | Shares withheld for taxes | −46,528 | $8.84 | $411,308 | 864,033 | D |
| Derivatives | |||||||
| Patel Chintu Co-CEO | 2025-03-03 | Option exercise · Performance-Based Restricted Stock Units | −579,710 | 0 | D | ||
| Patel Chintu Co-CEO | 2025-03-03 | Grant or award · Performance-Based Restricted Stock Units | +890,410 | 890,410 | D | ||
| Patel Chintu Co-CEO | 2025-03-03 | Grant or award · Restricted Stock Units | +239,726 | 239,726 | D | ||
| Patel Chintu Co-CEO | 2025-03-04 | Option exercise · Restricted Stock Units | −92,592 | 277,778 | D | ||
Loading xslF345X05/wk-form4_1741221088.xml…